144 related articles for article (PubMed ID: 11225989)
1. The murine CC chemokine, 6C-kine, inhibits tumor growth and angiogenesis in a human lung cancer SCID mouse model.
Arenberg DA; Zlotnick A; Strom SR; Burdick MD; Strieter RM
Cancer Immunol Immunother; 2001 Jan; 49(11):587-92. PubMed ID: 11225989
[TBL] [Abstract][Full Text] [Related]
2. Antitumor effects of the mouse chemokine 6Ckine/SLC through angiostatic and immunological mechanisms.
Vicari AP; Ait-Yahia S; Chemin K; Mueller A; Zlotnik A; Caux C
J Immunol; 2000 Aug; 165(4):1992-2000. PubMed ID: 10925282
[TBL] [Abstract][Full Text] [Related]
3. Cutting edge: species specificity of the CC chemokine 6Ckine signaling through the CXC chemokine receptor CXCR3: human 6Ckine is not a ligand for the human or mouse CXCR3 receptors.
Jenh CH; Cox MA; Kaminski H; Zhang M; Byrnes H; Fine J; Lundell D; Chou CC; Narula SK; Zavodny PJ
J Immunol; 1999 Apr; 162(7):3765-9. PubMed ID: 10201891
[TBL] [Abstract][Full Text] [Related]
4. The CXC chemokine, monokine induced by interferon-gamma, inhibits non-small cell lung carcinoma tumor growth and metastasis.
Addison CL; Arenberg DA; Morris SB; Xue YY; Burdick MD; Mulligan MS; Iannettoni MD; Strieter RM
Hum Gene Ther; 2000 Jan; 11(2):247-61. PubMed ID: 10680839
[TBL] [Abstract][Full Text] [Related]
5. Improved survival in tumor-bearing SCID mice treated with interferon-gamma-inducible protein 10 (IP-10/CXCL10).
Arenberg DA; White ES; Burdick MD; Strom SR; Strieter RM
Cancer Immunol Immunother; 2001 Dec; 50(10):533-8. PubMed ID: 11776375
[TBL] [Abstract][Full Text] [Related]
6. SLC/exodus2/6Ckine/TCA4 induces chemotaxis of hematopoietic progenitor cells: differential activity of ligands of CCR7, CXCR3, or CXCR4 in chemotaxis vs. suppression of progenitor proliferation.
Kim CH; Broxmeyer HE
J Leukoc Biol; 1999 Sep; 66(3):455-61. PubMed ID: 10496316
[TBL] [Abstract][Full Text] [Related]
7. The CC chemokine 6Ckine binds the CXC chemokine receptor CXCR3.
Soto H; Wang W; Strieter RM; Copeland NG; Gilbert DJ; Jenkins NA; Hedrick J; Zlotnik A
Proc Natl Acad Sci U S A; 1998 Jul; 95(14):8205-10. PubMed ID: 9653165
[TBL] [Abstract][Full Text] [Related]
8. Soluble expression of recombinant human secondary lymphoid chemokine (SLC) in E. coli and research on its in vitro and in vivo bioactivity.
Chun L; Yin CC; Song JZ; Liu MX; Piao JH; Lin Q; Wang XB; Huang HL
J Biochem; 2004 Dec; 136(6):769-76. PubMed ID: 15671487
[TBL] [Abstract][Full Text] [Related]
9. Depletion of CXCR2 inhibits tumor growth and angiogenesis in a murine model of lung cancer.
Keane MP; Belperio JA; Xue YY; Burdick MD; Strieter RM
J Immunol; 2004 Mar; 172(5):2853-60. PubMed ID: 14978086
[TBL] [Abstract][Full Text] [Related]
10. PPAR-gamma activation inhibits angiogenesis by blocking ELR+CXC chemokine production in non-small cell lung cancer.
Keshamouni VG; Arenberg DA; Reddy RC; Newstead MJ; Anthwal S; Standiford TJ
Neoplasia; 2005 Mar; 7(3):294-301. PubMed ID: 15799829
[TBL] [Abstract][Full Text] [Related]
11. Cutting edge: activity of human adult microglia in response to CC chemokine ligand 21.
Dijkstra IM; Hulshof S; van der Valk P; Boddeke HW; Biber K
J Immunol; 2004 Mar; 172(5):2744-7. PubMed ID: 14978072
[TBL] [Abstract][Full Text] [Related]
12. The angiostatic activity of interferon-inducible protein-10/CXCL10 in human melanoma depends on binding to CXCR3 but not to glycosaminoglycan.
Yang J; Richmond A
Mol Ther; 2004 Jun; 9(6):846-55. PubMed ID: 15194051
[TBL] [Abstract][Full Text] [Related]
13. Antagonism of CXCR3 inhibits lung metastasis in a murine model of metastatic breast cancer.
Walser TC; Rifat S; Ma X; Kundu N; Ward C; Goloubeva O; Johnson MG; Medina JC; Collins TL; Fulton AM
Cancer Res; 2006 Aug; 66(15):7701-7. PubMed ID: 16885372
[TBL] [Abstract][Full Text] [Related]
14. Interferon-gamma-inducible protein 10 (IP-10) is an angiostatic factor that inhibits human non-small cell lung cancer (NSCLC) tumorigenesis and spontaneous metastases.
Arenberg DA; Kunkel SL; Polverini PJ; Morris SB; Burdick MD; Glass MC; Taub DT; Iannettoni MD; Whyte RI; Strieter RM
J Exp Med; 1996 Sep; 184(3):981-92. PubMed ID: 9064358
[TBL] [Abstract][Full Text] [Related]
15. Effects of chemokines on proliferation and apoptosis of human mesangial cells.
Wörnle M; Schmid H; Merkle M; Banas B
BMC Nephrol; 2004 Jul; 5():8. PubMed ID: 15265234
[TBL] [Abstract][Full Text] [Related]
16. Association between the expression of chemokine receptors CCR7 and CXCR3, and lymph node metastatic potential in lung adenocarcinoma.
Maekawa S; Iwasaki A; Shirakusa T; Kawakami T; Yanagisawa J; Tanaka T; Shibaguchi H; Kinugasa T; Kuroki M; Kuroki M
Oncol Rep; 2008 Jun; 19(6):1461-8. PubMed ID: 18497951
[TBL] [Abstract][Full Text] [Related]
17. Blockade of CXCR3 receptor:ligand interactions reduces leukocyte recruitment to the lung and the severity of experimental idiopathic pneumonia syndrome.
Hildebrandt GC; Corrion LA; Olkiewicz KM; Lu B; Lowler K; Duffner UA; Moore BB; Kuziel WA; Liu C; Cooke KR
J Immunol; 2004 Aug; 173(3):2050-9. PubMed ID: 15265940
[TBL] [Abstract][Full Text] [Related]
18. Critical role for CXCR3 chemokine biology in the pathogenesis of bronchiolitis obliterans syndrome.
Belperio JA; Keane MP; Burdick MD; Lynch JP; Xue YY; Li K; Ross DJ; Strieter RM
J Immunol; 2002 Jul; 169(2):1037-49. PubMed ID: 12097412
[TBL] [Abstract][Full Text] [Related]
19. The CXCR3 targeting chemokine CXCL11 has potent antitumor activity in vivo involving attraction of CD8+ T lymphocytes but not inhibition of angiogenesis.
Hensbergen PJ; Wijnands PG; Schreurs MW; Scheper RJ; Willemze R; Tensen CP
J Immunother; 2005; 28(4):343-51. PubMed ID: 16000952
[TBL] [Abstract][Full Text] [Related]
20. Secondary lymphoid tissue chemokine mediates T cell-dependent antitumor responses in vivo.
Sharma S; Stolina M; Luo J; Strieter RM; Burdick M; Zhu LX; Batra RK; Dubinett SM
J Immunol; 2000 May; 164(9):4558-63. PubMed ID: 10779757
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
